189
Participants
Start Date
November 17, 2016
Primary Completion Date
June 14, 2021
Study Completion Date
June 14, 2021
invasive Hemodynamic monitoring via Clearsight/Nexfin Systems from Edwards Lifesciences
Experimental: Hemodynamic Monitored Guided Assesment This group will have the non-invasive hemodynamic monitoring device placed and its data will help guide (intervention) patient's management decisions (experimental).
No Hemodynamic Monitored Guided Assesment
Arm: Active Comparator: No Hemodynamic Monitored Guided Assesment This group will have the non-invasive hemodynamic monitoring device placed but its data will NOT be factored for intervention of the patient's management decisions.
Loma Linda Health, Loma Linda
Loma Linda University Department of Anesthesiology, Loma Linda
Pat Moore, Loma Linda
Collaborators (1)
Edwards Lifesciences
INDUSTRY
Loma Linda University
OTHER